Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vaccination site discomfort, Vaccination site rash
Clinical narrative: making her ill; cold; rash was so bad it went across her chest; the rash got down to her elbow.; she might have gotten a fever; rash at the injection site; discomfort in the arm; chills; horrible Nausea; nurse told her she should be okay with this vaccine since it is only half the dose.; stomach cramps; itching; She could not eat or drink anything for 2 days; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (making her ill), NASOPHARYNGITIS (cold), ABDOMINAL PAIN UPPER (stomach cramps), PRURITUS (itching) and DECREASED APPETITE (She could not eat or drink anything for 2 days) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concurrent medical conditions included Drug allergy (highly allergic to sulfa drug.).    On 31-Jul-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2023, the patient experienced DECREASED APPETITE (She could not eat or drink anything for 2 days). On 31-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced ABDOMINAL PAIN UPPER (stomach cramps), PRURITUS (itching), CHILLS (chills), NAUSEA (horrible Nausea) and UNDERDOSE (nurse told her she should be okay with this vaccine since it is only half the dose.). On 07-Aug-2023, the patient experienced VACCINATION SITE DISCOMFORT (discomfort in the arm). On an unknown date, the patient experienced ILLNESS (making her ill), NASOPHARYNGITIS (cold), PYREXIA (she might have gotten a fever), VACCINATION SITE RASH (rash at the injection site), RASH (rash was so bad it went across her chest) and RASH (the rash got down to her elbow.). On 03-Aug-2023, DECREASED APPETITE (She could not eat or drink anything for 2 days) had resolved. At the time of the report, ILLNESS (making her ill), NASOPHARYNGITIS (cold), ABDOMINAL PAIN UPPER (stomach cramps), PRURITUS (itching), CHILLS (chills), PYREXIA (she might have gotten a fever), VACCINATION SITE RASH (rash at the injection site), VACCINATION SITE DISCOMFORT (discomfort in the arm), RASH (rash was so bad it went across her chest), RASH (the rash got down to her elbow.), NAUSEA (horrible Nausea) and UNDERDOSE (nurse told her she should be okay with this vaccine since it is only half the dose.) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. The patient had a small house and could not walk to the bathroom. The patient had chills. The patient thinks that the patient might had gotten a fever but could not check since the patient does not have a thermometer. The patient was shaking really bad because the patient was so cold. The patient was itching and had a rash at the injection site. The rash was so bad it went across the chest. Within 30 second of getting the vaccine it started itching. Then the rash got down to the elbow. On 07-Aug-2023, the patient had itching and discomfort in the arm. 10 hours After getting the vaccine, the patient had really severe stomach cramps, horrible nausea, and chills. The patient could not eat or drink anything for 2 days. On the 3rd morning, the patient could eat again. The patient could eat a solid meal. The patient did not have diarrhea. The patient's doctor and nurse told that the patient should be okay with this vaccine since it was only half the dose.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-736833 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-736833:Monovalent case